biostudies-literatureUnknown5(5)Hanessian SIn connection with a program directed at potent and balanced dual NK1/NK3 receptor ligands, a focused exploration of an original class of peptidomimetic derivatives was performed. The rational design and molecular hybridization of a novel phenylalanine core series was achieved to maximize the in vitro affinity and antagonism at both human NK1 and NK3 receptors. This study led to the identification of a new potent dual NK1/NK3 antagonist with pK i values of 8.6 and 8.1, respectively.ACS medicinal chemistry letters550-5https://www.ebi.ac.uk/biostudies/studies/S-EPMC4027792biostudies-literatureDesign, Synthesis, and Optimization of Balanced Dual NK1/NK3 Receptor Antagonists.PMC4027792Millan MJSoma UMannoury la Cour CHanessian SBoyer NDe Nanteuil GBabonneau VJennequin TfalseDesign, Synthesis, and Optimization of Balanced Dual NK1/NK3 Receptor Antagonists.In connection with a program directed at potent and balanced dual NK1/NK3 receptor ligands, a focused exploration of an original class of peptidomimetic derivatives was performed. The rational design and molecular hybridization of a novel phenylalanine core series was achieved to maximize the in vitro affinity and antagonism at both human NK1 and NK3 receptors. This study led to the identification of a new potent dual NK1/NK3 antagonist with pK i values of 8.6 and 8.1, respectively.2014-01-01T00:00:00Z2014 May2025-04-22T17:42:50.139Z2019-03-27T01:28:35ZS-EPMC40277922490087810.1021/ml400528y